A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults
Clinical trial NCT04584710 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04584710
- Sponsor
- Restorbio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-13
- Primary completion
- 2021-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.